Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Created by geldnutzer 

Aptevo Therapeutics Inc diskutieren

Published 04.01.17
Prediction Buy
Perf. (%) -24.44%
Target price 4.420
Change

Im Biotechbereich interessant, es lohnt sich, wenn die Produkte positiv vermarktet werden.

Ich bin Ende des Jahres auf diesen Wert aufmerksam geworden, jetzt steigt die Aktie stark, jeder sollte sich eine Meinung bilden, aber die Aussichten sehen gut aus. Hier die News:

positive Studiendaten für seinen in Phase 2 befindlichen Wirkstoff  Otlertuzumab.





Published 26.01.17
Prediction Buy
Perf. (%) -24.44%
Target price 4.420
Change

(Vom Mitglied beendet)

Published 06.02.19
Prediction Buy
Perf. (%) -10.63%
Target price 4.510
Change

Boden

auch hier erreicht?

Published 14.02.19
Prediction Buy
Perf. (%) -10.63%
Target price 4.510
Change

(Stop Loss Kurs erreicht)

Published 16.02.19
Prediction Buy
Perf. (%) -46.93%
Target price 3.608
Change

Geht

hier Was?

Published 13.03.19
Prediction Buy
Perf. (%) -46.93%
Target price 3.608
Change

(Vom Mitglied beendet)

Published 02.07.19
Prediction Buy
Perf. (%) 133.14%
Target price 1.804
Change

Hohes

Volumen.

Published 12.03.20
Prediction Buy
Perf. (%) 588.03%
Target price 1.200
Change

Buy mit Kursziel 1,2

Buy Aptevo Therapeutics Inc.

Buy Aptevo Therapeutics Inc.

Buy Aptevo Therapeutics Inc.

Buy Aptevo Therapeutics Inc.

Buy Aptevo Therapeutics Inc.

Buy Aptevo Therapeutics Inc.

Published 31.07.20
Prediction Sell
Perf. (%) -5.56%
Target price
Change

Sell Aptevo Therapeutics Inc.

Sell Aptevo Therapeutics Inc.

Sell Aptevo Therapeutics Inc.

Sell Aptevo Therapeutics Inc.

Sell Aptevo Therapeutics Inc.

Sell Aptevo Therapeutics Inc.

You are not allowed to take part in this discussion. If you have any questions please contact the thread starter.